$ITOX Cashflow Statement | Understand Stock

$ITOX

$0.00 +$0.00 (13.21%) Close

$ITOX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows from Operating Activities
Net loss
Adjustments to reconcile net loss to net cash (used in) provided by operating activities
Loss on Extinguishment of Debt
Loss on Issuance of Default Warrants
Loss due to Change in Fair Market Value of Derivative Liability
Loss on Derivative Liability
Preferred Stock Issued for Services
Penalty and Fees Incurred due to Default Increase in Notes Payable
Bad debts
Discount on note receivable
Forgiveness of PPP Loan
Debt discount on notes payable
Beneficial conversion feature
Amortization of beneficial conversion feature
Amortization of intangible assets
Amortization of Series B Preferred Stock to redemption
Loss on change in FMV of derivatives
Loss on extinguishment of notes payable
Write-down of intangible assets
Common stock issued for services
Amortization of debt discount on Series B and D Preferred Stock
(Gain) loss on change in fair value of derivative liability
Decrease in accounts receivable
Prepaid expense
Decrease in prepaid expenses and other current assets
(Decrease) Increase in accounts payable
Increase in accrued liabilities
Increase in derivative liability
Decrease in unearned interest
(Decrease) in deferred revenue
(Decrease) increase in shares payable to related parties
Salaries payable to related parties
Increase in salaries payable to related parties

Net Cash Used in Operating Activities
Net Cash Used in Investing Activities
Cash Flows from Financing Activities
Cash received from Convertible Note Payable
Cash Payments of Notes Payable
Proceeds from sale of Series B Preferred Stock
Proceeds from PPP Loan
Cash received from sale of common stock, net
Cash received from sale of Series B Preferred Stock
Cash received from sale of Series D Preferred Stock
Cash paid for offering costs

Net Cash Provided by Financing Activities
Net Increase in Cash and Cash Equivalents
Cash and Cash Equivalents - Beginning of Period
Cash and Cash Equivalents - End of Period
Supplement Disclosures of Cash Flow Information
Interest paid
Income taxes paid
Supplemental Disclosures of Non-Cash Investing and Financing Activities
Discount on notes payable
Conversion of convertible notes payable and derivative liabilities
Warrant anti-dilution issuance
Deferred financing cost on notes payable
Discount on Series B Convertible Preferred Stock
Common stock issued in settlement of accounts payable
Issuance of Series E Preferred stock in settlement of compensation payable

Comments